237 related articles for article (PubMed ID: 37941063)
21. High-expression of LncRNA MAFG-AS1 is associated with the prognostic of patients with colorectal cancer.
Cui W; Wang Y; Shen X; Wu X; Liu H; Xu X
Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1530-1535. PubMed ID: 33295405
[TBL] [Abstract][Full Text] [Related]
22. MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis.
Xiang L; Zeng Q; Liu J; Xiao M; He D; Zhang Q; Xie D; Deng M; Zhu Y; Liu Y; Bo H; Liu X; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Cao K
Sci Bull (Beijing); 2021 Sep; 66(17):1773-1788. PubMed ID: 36654385
[TBL] [Abstract][Full Text] [Related]
23. LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression.
Ye C; Qin S; Guo F; Yang Y; Wang H; Zhang C; Yang B
J Cancer; 2022; 13(1):146-152. PubMed ID: 34976178
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of long non-coding RNA MAFG-AS1 represses tumorigenesis of colorectal cancer cells through the microRNA-149-3p-dependent inhibition of HOXB8.
Ruan Z; Deng H; Liang M; Xu Z; Lai M; Ren H; Deng X; Su X
Cancer Cell Int; 2020; 20():511. PubMed ID: 33093810
[TBL] [Abstract][Full Text] [Related]
25. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
26. A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism.
Pradas-Juni M; Hansmeier NR; Link JC; Schmidt E; Larsen BD; Klemm P; Meola N; Topel H; Loureiro R; Dhaouadi I; Kiefer CA; Schwarzer R; Khani S; Oliverio M; Awazawa M; Frommolt P; Heeren J; Scheja L; Heine M; Dieterich C; Büning H; Yang L; Cao H; Jesus DF; Kulkarni RN; Zevnik B; Tröder SE; Knippschild U; Edwards PA; Lee RG; Yamamoto M; Ulitsky I; Fernandez-Rebollo E; Vallim TQA; Kornfeld JW
Nat Commun; 2020 Jan; 11(1):644. PubMed ID: 32005828
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA MAFG-AS1 facilitates the progression of hepatocellular carcinoma via targeting miR-3196/OTX1 axis.
Hu ZQ; Li HC; Teng F; Chang QM; Wu XB; Feng JF; Zhang ZP
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12131-12143. PubMed ID: 33336731
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
Ouyang H; Zhang L; Xie Z; Ma S
Exp Ther Med; 2019 Oct; 18(4):2547-2553. PubMed ID: 31572506
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract][Full Text] [Related]
31. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
32. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
Zhang X; Zhao X; Chang L; Liu F; Li C; Ge P
Breast Cancer; 2022 Sep; 29(5):908-920. PubMed ID: 35678943
[TBL] [Abstract][Full Text] [Related]
33. MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression.
Li P; Shi Y; Guo M; Xu H; Zhan M; Wang Z; Chen Y
Front Oncol; 2022; 12():856580. PubMed ID: 35992831
[TBL] [Abstract][Full Text] [Related]
34. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316.
Wang F; Zu Y; Huang W; Chen H; Xie H; Yang Y
Biochem Biophys Res Commun; 2018 Sep; 504(1):171-176. PubMed ID: 30177388
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway.
Di S; Bai R; Lu D; Chen C; Ma T; Zou Z; Zhang Z
Cell Death Discov; 2022 May; 8(1):249. PubMed ID: 35513366
[TBL] [Abstract][Full Text] [Related]
36. Potential role of RAB6C-AS1 long noncoding RNA in different cancers.
Salavaty A; Motlagh FM; Barabadi M; Cheshomi H; Esmatabadi MJD; Shahmoradi M; Soleimanpour-Lichaei HR
J Cell Physiol; 2018 Jan; 234(1):891-903. PubMed ID: 30076712
[TBL] [Abstract][Full Text] [Related]
37. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
[TBL] [Abstract][Full Text] [Related]
38. MAFG-AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma.
Xiao M; Liu J; Xiang L; Zhao K; He D; Zeng Q; Zhang Q; Xie D; Deng M; Zhu Y; Zhang Y; Liu Y; Bo H; Liu X; Chen X; Gong L; Bao Y; Hu Y; Cheng Y; Deng L; Zhu R; Xing X; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Cao K
Clin Transl Med; 2020 Dec; 10(8):e241. PubMed ID: 33377647
[TBL] [Abstract][Full Text] [Related]
39. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axis.
Sun X; Cai Y; Hu X; Mo M; Zhao C; He W; Li Y
Transl Cancer Res; 2020 Nov; 9(11):7214-7226. PubMed ID: 35117325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]